{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:06:23Z","timestamp":1781625983177,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82002243"],"award-info":[{"award-number":["82002243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Projects of the Beijing Municipal Education Commission's Science and Technology Plan","award":["KZ202010025035"],"award-info":[{"award-number":["KZ202010025035"]}]},{"name":"Special key research project of capital health development scientific research","award":["SF2020-1-1151"],"award-info":[{"award-number":["SF2020-1-1151"]}]},{"DOI":"10.13039\/501100017616","name":"Beijing Talents foundation","doi-asserted-by":"crossref","award":["2018000021469G289"],"award-info":[{"award-number":["2018000021469G289"]}],"id":[{"id":"10.13039\/501100017616","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Hospitals Authority Youth Programme","award":["QML20201702"],"award-info":[{"award-number":["QML20201702"]}]},{"name":"The Beijing Municipal Institute of Public Medical Research Development and Reform Pilot Project","award":["JYY2021-10"],"award-info":[{"award-number":["JYY2021-10"]}]},{"name":"Talent Cultivation plan of \"Climbing the peak\" of Beijing Municipal Hospital Administration","award":["DFL20221503"],"award-info":[{"award-number":["DFL20221503"]}]},{"name":"High-level public health technical personnel construction Project","award":["Subject leaders-02-13"],"award-info":[{"award-number":["Subject leaders-02-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human immunodeficiency virus (HIV) is a genus of retroviruses that targets immune cells and may eventually cause immune-deficiency illness. Triple infection of HIV\/hepatitis B virus (HBV) \/tuberculosis (TB) leads to a worse prognosis than mono-infection. We aimed to unveil the pooled estimation of HIV\/HBV\/TB co-infection prevalence in Asia, South America, and Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search in PubMed, Embase, and the Cochrane Library was performed for studies of the prevalence of HIV\/HBV\/TB triple infection published from January 1, 1990, to March 31, 2024. The Freeman\u2013Tukey random effects model was used to calculate the pooled prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 7 studies with in total 6401 participants and 259 triple infection cases. The pooled triple infection rate in the enrolled population was 4.4% (259\/6401; 95% CI 2.2%-7.3%). The results of the subgroup analysis showed that the prevalence of triple infection was significantly higher in the South America (82\/950, 8.6%; 95% CI 6.8%-10.4%), in men (86\/1817, 3.4%; 95% CI 0.7%-7.8%) and patients receiving antiretroviral treatment (125\/1611, 7.4%; 95% CI 5.8%\u20139.2%). However, no significant difference in the triple infection rate was observed among individuals initially diagnosed with HIV or TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis suggests that the prevalence of HIV\/HBV\/TB triple infection in the regions studied is underestimated, and we should focus more effort on improving novel strategies for identifying triple infection of HIV\/HBV\/TB. However, additional studies are required to be incorporated in future analyses to provide a pooled estimate of the global pooled prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12390-4","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T09:15:09Z","timestamp":1766222109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the underestimated prevalence of HIV, HBV and TB triple infection in Asia, South America, and Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yinkang","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"12390_CR1","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","volume":"1","author":"S Deeks","year":"2015","unstructured":"Deeks S, Overbaugh J, Phillips A, et al. HIV infection. Nat Rev Dis Primers. 2015;1:15035. https:\/\/doi.org\/10.1038\/nrdp.2015.35.","journal-title":"Nat Rev Dis Primers"},{"key":"12390_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","volume":"9","author":"LG Bekker","year":"2023","unstructured":"Bekker LG, Beyrer C, Mgodi N, et al. HIV infection. Nat Rev Dis Primers. 2023;9:42. https:\/\/doi.org\/10.1038\/s41572-023-00452-3.","journal-title":"Nat Rev Dis Primers"},{"key":"12390_CR3","volume-title":"Licence: CC BY-NC-SA 3.0 IGO","author":"Global tuberculosis report 2024","year":"2024","unstructured":"Global tuberculosis report 2024. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2024."},{"issue":"4","key":"12390_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2213-2600(14)70031-1","volume":"2","author":"K Dheda","year":"2014","unstructured":"Dheda K, Gumbo T, Gandhi NR, et al. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014;2(4):321\u201338. https:\/\/doi.org\/10.1016\/S2213-2600(14)70031-1.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"12390_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12879-023-08575-4","volume":"23","author":"CC Qi","year":"2023","unstructured":"Qi CC, Xu LR, Zhao CJ, et al. Prevalence and risk factors of tuberculosis among people living with HIV\/AIDS in china: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):584. https:\/\/doi.org\/10.1186\/s12879-023-08575-4.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12390_CR6","doi-asserted-by":"publisher","first-page":"18360","DOI":"10.1038\/s41598-022-23316-4","volume":"12","author":"ME Lelisho","year":"2022","unstructured":"Lelisho ME, Wotale TW, Tareke SA, et al. Survival rate and predictors of mortality among TB\/HIV co-infected adult patients: retrospective cohort study. Sci Rep. 2022;12(1):18360. https:\/\/doi.org\/10.1038\/s41598-022-23316-4.","journal-title":"Sci Rep"},{"key":"12390_CR7","unstructured":"Global hepatitis report. 2024: action for access in low- and middle-income countries. Geneva:World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"12390_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/2394-5079.2022.32","volume":"8","author":"Q Wan","year":"2022","unstructured":"Wan Q, Anugwom C, Desalegn H, et al. Hepatocellular carcinoma in hepatitis B and human immunodeficiency virus coinfection in africa: a focus on surveillance. Hepatoma Res. 2022;8:39. https:\/\/doi.org\/10.20517\/2394-5079.2022.32.","journal-title":"Hepatoma Res"},{"key":"12390_CR9","doi-asserted-by":"publisher","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","volume":"8","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Lin P, Cheng N. HBV\/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med (Lausanne). 2021;8:713981. https:\/\/doi.org\/10.3389\/fmed.2021.713981.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"12390_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"27","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat. 2020;27(3):294\u2013315. https:\/\/doi.org\/10.1111\/jvh.13217.","journal-title":"J Viral Hepat"},{"issue":"4","key":"12390_CR11","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.7759\/cureus.14433","volume":"13","author":"AF Khan","year":"2021","unstructured":"Khan AF, Sajjad A, Mian DA, et al. Co-infection with hepatitis B in tuberculosis patients on Anti-tuberculosis treatment and the final outcome. Cureus. 2021;13(4):e14433. https:\/\/doi.org\/10.7759\/cureus.14433. Published 2021 Apr 12.","journal-title":"Cureus"},{"issue":"7","key":"12390_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MCG.0000000000001533","volume":"56","author":"RJ Wong","year":"2022","unstructured":"Wong RJ, Hubbard A, Bagley L, et al. Estimating prevalence of hepatitis B virus coinfection among adults with tuberculosis: A systematic review with Meta-analysis. J Clin Gastroenterol. 2022;56(7):601\u201317. https:\/\/doi.org\/10.1097\/MCG.0000000000001533.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"12390_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4314\/ejhs.v23i3.4","volume":"23","author":"W Mulu","year":"2013","unstructured":"Mulu W, Gidey B, Chernet A, et al. Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot referral Hospital, Bahirdar, Ethiopia. Ethiop J Health Sci. 2013;23(3):217\u201326. https:\/\/doi.org\/10.4314\/ejhs.v23i3.4.","journal-title":"Ethiop J Health Sci"},{"issue":"9","key":"12390_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD2019HB Collaborators","year":"2022","unstructured":"Collaborators GBD2019HB. Global, regional, and National burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829. https:\/\/doi.org\/10.1016\/S2468-1253(22)00124-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12390_CR15","doi-asserted-by":"publisher","unstructured":"Maynard JE. Hepatitis B: global importance and need for control. Vaccine. 1990;8. https:\/\/doi.org\/10.1016\/0264-410x(90)90209-5. Suppl:S18-20; discussion S21-3.","DOI":"10.1016\/0264-410x(90)90209-5"},{"key":"12390_CR16","doi-asserted-by":"publisher","first-page":"107876","DOI":"10.1016\/j.ijid.2025.107876","volume":"155","author":"B Sossen","year":"2025","unstructured":"Sossen B, Kubjane M, Meintjes G. Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality. Int J Infect Dis. 2025;155:107876. https:\/\/doi.org\/10.1016\/j.ijid.2025.107876.","journal-title":"Int J Infect Dis"},{"key":"12390_CR17","volume-title":"Intensified case finding (ICF), Isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV","author":"World Health Organization. WHO THREE I\u2019s MEETING","year":"2008","unstructured":"World Health Organization. WHO THREE I\u2019s MEETING. Intensified case finding (ICF), Isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Geneva: World Health Organization; 2008."},{"key":"12390_CR18","volume-title":"prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","author":"Guidelines for the","year":"2024","unstructured":"Guidelines for the. prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024. Licence: CC BYNC-SA 3.0 IGO."},{"key":"12390_CR19","volume-title":"Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV","author":"M Unemo","year":"2023","unstructured":"Unemo M, Cole M, Lewis D, et al. Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"12390_CR20","volume-title":"Universal access to rapid tuberculosis diagnostics","author":"WHO standard","year":"2023","unstructured":"WHO standard. Universal access to rapid tuberculosis diagnostics. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"12390_CR21","unstructured":"WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis \u2013 Rapid diagnostics for tuberculosis detection [Internet]. Geneva: World Health Organization. 2024. 2, Recommendations. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK602012\/"},{"issue":"9","key":"12390_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"12390_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"12390_CR24","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/IDR.S410260","volume":"16","author":"K Gebrehiwet","year":"2023","unstructured":"Gebrehiwet K, Biranu E, Nigatu W, et al. Prevalence of hepatitis B virus, human immune deficiency virus and associated risk factors among individuals with presumptive pulmonary tuberculosis attending at saint peter\u2019s specialized Hospital, addis Ababa, Ethiopia. Infect Drug Resist. 2023;16:3965\u201379. https:\/\/doi.org\/10.2147\/IDR.S410260.","journal-title":"Infect Drug Resist"},{"issue":"11","key":"12390_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/pathogens9110950","volume":"9","author":"BB Phinius","year":"2020","unstructured":"Phinius BB, Anderson M, Bhebhe L, et al. Increased prevalence of liver fibrosis and HIV viremia among patients with HIV, HBV, and tuberculosis in Botswana. Pathogens. 2020;9(11):950. https:\/\/doi.org\/10.3390\/pathogens9110950.","journal-title":"Pathogens"},{"key":"12390_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s12879-020-05575-6","volume":"20","author":"N Msomi","year":"2020","unstructured":"Msomi N, Naidoo K, Yende-Zuma N, et al. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. BMC Infect Dis. 2020;20:847. https:\/\/doi.org\/10.1186\/s12879-020-05575-6.","journal-title":"BMC Infect Dis"},{"key":"12390_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijid.2014.06.020","volume":"28","author":"P Mo","year":"2014","unstructured":"Mo P, Zhu Q, Teter C, et al. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus. Int J Infect Dis. 2014;28:95\u2013100. https:\/\/doi.org\/10.1016\/j.ijid.2014.06.020.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"12390_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcv.2012.04.006","volume":"54","author":"RS Aires","year":"2012","unstructured":"Aires RS, Matos MA, Lopes CL, et al. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goi\u00e2nia City, Brazil. J Clin Virol. 2012;54(4):327\u201331. https:\/\/doi.org\/10.1016\/j.jcv.2012.04.006.","journal-title":"J Clin Virol"},{"key":"12390_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2458-8-245","volume":"8","author":"C Sirinak","year":"2008","unstructured":"Sirinak C, Kittikraisak W, Pinjeesekikul D, et al. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand. BMC Public Health. 2008;8:245. https:\/\/doi.org\/10.1186\/1471-2458-8-245.","journal-title":"BMC Public Health"},{"issue":"Pt 2","key":"12390_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1099\/jmm.0.47492-0","volume":"57","author":"MA Pando","year":"2008","unstructured":"Pando MA, De Salvo C, Bautista CT, et al. Human immunodeficiency virus and tuberculosis in argentina: prevalence, genotypes and risk factors. J Med Microbiol. 2008;57(Pt 2):190\u20137. https:\/\/doi.org\/10.1099\/jmm.0.47492-0.","journal-title":"J Med Microbiol"},{"issue":"11","key":"12390_CR31","doi-asserted-by":"publisher","first-page":"e37016","DOI":"10.2196\/37016","volume":"8","author":"S Chen","year":"2022","unstructured":"Chen S, Ren F, Huang X, et al. Underestimated prevalence of HIV, hepatitis B virus (HBV), and hepatitis D virus (HDV) triple infection globally: systematic review and Meta-analysis. JMIR Public Health Surveill. 2022;8(11):e37016. https:\/\/doi.org\/10.2196\/37016.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"12390_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.mpmed.2022.01.002","volume":"50","author":"V Delpech","year":"2022","unstructured":"Delpech V. The HIV epidemic: global and united Kingdom trends. Med (Abingdon). 2022;50(4):202\u20134. https:\/\/doi.org\/10.1016\/j.mpmed.2022.01.002.","journal-title":"Med (Abingdon)"},{"issue":"10290","key":"12390_CR33","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(21)01167-3","volume":"397","author":"C Beyrer","year":"2021","unstructured":"Beyrer C. A pandemic anniversary: 40 years of HIV\/AIDS. Lancet. 2021;397(10290):2142\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(21)01167-3.","journal-title":"Lancet"},{"key":"12390_CR34","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.lana.2025.101045","volume":"44","author":"MA Garcia-Bereguiain","year":"2025","unstructured":"Garcia-Bereguiain MA, Rodriguez-Pazmi\u00f1o AS, Franco-Sotomayor G, et al. The end TB strategy pathway in South america: out of track for 2025 milestones and 2035 eradication. Lancet Reg Health Am. 2025;44:101045. https:\/\/doi.org\/10.1016\/j.lana.2025.101045.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"12390_CR35","doi-asserted-by":"publisher","first-page":"e0226","DOI":"10.1097\/CLD.0000000000000226","volume":"23","author":"L Haddad","year":"2024","unstructured":"Haddad L, Gadano A. HBV elimination in central and South america: current status and challenges. Clin Liver Dis (Hoboken). 2024;23(1):e0226. https:\/\/doi.org\/10.1097\/CLD.0000000000000226.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"12390_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/tmi.14070","volume":"30","author":"MC Magri","year":"2025","unstructured":"Magri MC, Manchiero C, Dantas BP, et al. HBV, HCV and HIV among inmates in Latin America and the caribbean: A systematic review and meta-analysis. Trop Med Int Health. 2025;30(1):4\u201313. https:\/\/doi.org\/10.1111\/tmi.14070.","journal-title":"Trop Med Int Health"},{"issue":"10","key":"12390_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"12390_CR38","doi-asserted-by":"publisher","first-page":"698121","DOI":"10.3389\/fimmu.2021.698121","volume":"12","author":"L Gay","year":"2021","unstructured":"Gay L, Melenotte C, Lakbar I, et al. Sexual dimorphism and gender in infectious diseases. Front Immunol. 2021;12:698121. https:\/\/doi.org\/10.3389\/fimmu.2021.698121.","journal-title":"Front Immunol"},{"issue":"1","key":"12390_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/emj.20.1.54","volume":"20","author":"CJ Mann","year":"2003","unstructured":"Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54\u201360. https:\/\/doi.org\/10.1136\/emj.20.1.54.","journal-title":"Emerg Med J"},{"issue":"5","key":"12390_CR40","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","volume":"10","author":"A Trickey","year":"2023","unstructured":"Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North america: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295\u2013307. https:\/\/doi.org\/10.1016\/S2352-3018(23)00028-0.","journal-title":"Lancet HIV"},{"issue":"4","key":"12390_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","volume":"5","author":"C Luchini","year":"2017","unstructured":"Luchini C, Stubbs B, Solmi M, et al. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa scale. World J Meta-Anal. 2017;5(4):80\u20134. https:\/\/doi.org\/10.13105\/wjma.v5.i4.80.","journal-title":"World J Meta-Anal"},{"issue":"9","key":"12390_CR42","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2013.03.003","volume":"66","author":"L Hartling","year":"2013","unstructured":"Hartling L, Milne A, Hamm MP, et al. Testing the Newcastle Ottawa scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013;66(9):982\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.03.003.","journal-title":"J Clin Epidemiol"},{"key":"12390_CR43","doi-asserted-by":"publisher","first-page":"2697618","DOI":"10.1155\/2019\/2697618","volume":"2019","author":"C Twumasi","year":"2019","unstructured":"Twumasi C, Asiedu L, Nortey ENN. Statistical modeling of HIV, Tuberculosis, and hepatitis B transmission in Ghana. Can J Infect Dis Med Microbiol. 2019;2019:2697618. https:\/\/doi.org\/10.1155\/2019\/2697618.","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12390-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:30:13Z","timestamp":1781623813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12390-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12390"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12390-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}